NicolasMusiMD

Endocrinology • Los Angeles, CA

Diabetes, Lipid Metabolism

Professor and Director, Endocrinology Division, Cedars-Sinai Medical Center

Join to view full profile

Dr. Musi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Musi's full profile

Already have an account?

Office
8723 Alden Dr
Los Angeles, CA 90048
Phone+1 310-423-3870

Fax+1 310-423-0429

Education & Training

University of Miami/Jackson Health SystemResidency, Internal Medicine, 1995 - 1998
Universidad Anahuac School of MedicineClass of 1995

Certifications & Licensure

CA State Medical License 2022 - 2026
TX State Medical License 2005 - 2024
MA State Medical License 1998 - 2006
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Acute Effect of Exenatide on Brain Glucose Metabolism Start of enrollment: 2010 Jul 01
Completed
Phase 4
Effect of Age on Glucose and Lipid Metabolism Start of enrollment: 2010 Sep 01
Completed
Not Applicable
A Study to Evaluate the Effect of Lipid Infusion on Toll Like Receptor 4 (TLR4) Signaling Start of enrollment: 2008 Jan 01
Completed
Not Applicable
Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim 1) Start of enrollment: 2014 Apr 02
Completed
Phase 2
Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim2) Start of enrollment: 2014 Apr 10
Completed
Phase 2
Senolytic Therapy to Modulate Progression of Alzheimer's Disease Start of enrollment: 2020 Feb 14
Completed
Phase 1, Phase 2
Pilot Study to Investigate the Safety and Feasibility of AntiRetroviral Therapy for Alzheimer's Disease Start of enrollment: 2021 Feb 15
COMPLETED
PHASE1, PHASE2
Single Nuclei RNA-seq to Map Adipose Cellular Populations and Senescent Cells in Older Subjects Start of enrollment: 2023 Oct 17
RECRUITING
PHASE2, PHASE3
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

BIO101 in Sarcopenic Seniors at Risk of Mobility Disability: Results of a Double-Blind Randomised Interventional Phase 2b Trial.
Roger A Fielding, Michael M Dao, Kevin Cannon, Moise Desvarieux, Sam S Miller
Journal of Cachexia, Sarcopenia and Muscle. 2025-04-01
A Phase IIa clinical trial to evaluate the effects of anti-retroviral therapy in Alzheimer's disease (ART-AD).
A Campbell Sullivan, Gabrielle Zuniga, Paulino Ramirez, Roman Fernandez, Chen-Pin Wang
NPJ Dementia. 2025-01-01
1 citations
Effect of Semaglutide on Physical Function, Body Composition, and Biomarkers of Aging in Older Adults With Overweight and Insulin Resistance: Protocol for an Open-Labe...
Tiffany M Cortes, Libia Vasquez, Monica C Serra, Ronna Robbins, Allison Stepanenko
JMIR Research Protocols. 2024-09-13

Journal Articles

NFB Regulates Muscle Development and Mitochondrial Function
Robert L Reddick, Nicolas Musi, The Journals of Gerontology

Lectures

SAD-A Promotes Glucose-Stimulated Insulin Secretion Through Phosphorylation and Inhibition of GDIα in Male Islet Β-cells
San Antonio, TX - 6/16/2014
SAD-A Promotes Glucose-Stimulated Insulin Secretion Through Phosphorylation and Inhibition of GDIα in Male Islet Β-cells
San Antonio, TX - 6/16/2014
SAD-A Promotes Glucose-Stimulated Insulin Secretion Through Phosphorylation and Inhibition of GDIα in Male Islet Β-cells
San Antonio, TX - 6/16/2014

Press Mentions

UConn Center on Aging to Transform Our Understanding of Cellular Senescence in Human Aging with NIH-Funded Tissue Mapping Center DiscoveriesDecember 22nd, 2022
Liver Enzyme Might Hold the Secret to New Obesity TreatmentsApril 11th, 2022
Boosting Liver mRNAs Curbs Appetite, Body Weight in Obese MiceApril 5th, 2022
Join now to see all

Grant Support

Targeting Biology of Aging Mechanisms Underlying Alzheimer's Disease Risk with MetforminCEDARS-SINAI MEDICAL CENTER2024–2029
Targeting Biology of Aging Mechanisms Underlying Alzheimer's Disease Risk with MetforminCEDARS-SINAI MEDICAL CENTER2024–2029
Targeting Biology of Aging Mechanisms Underlying Alzheimer's Disease Risk with MetforminCEDARS-SINAI MEDICAL CENTER2024–2029
Single nuclei RNA-sequencing to map adipose cellular populations and senescent cells in older subjectsCEDARS-SINAI MEDICAL CENTER2022–2027
The KAPP-Sen Tissue Mapping Center CollaborativeUNIVERSITY OF CONNECTICUT SCH OF MED/DNT2021–2026
The KAPP-Sen Tissue Mapping Center CollaborativeUNIVERSITY OF CONNECTICUT SCH OF MED/DNT2021–2026
The KAPP-Sen Tissue Mapping Center CollaborativeUNIVERSITY OF CONNECTICUT SCH OF MED/DNT2021–2026
Does Metformin Modulate the Pillars of Aging in Older Adults?CEDARS-SINAI MEDICAL CENTER2020–2025
Does Metformin Modulate the Pillars of Aging in Older Adults?CEDARS-SINAI MEDICAL CENTER2020–2025
Does Metformin Modulate the Pillars of Aging in Older Adults?CEDARS-SINAI MEDICAL CENTER2020–2025
Does Metformin Modulate the Pillars of Aging in Older Adults?CEDARS-SINAI MEDICAL CENTER2020–2025
Metformin for Preventing Frailty in High Risk Older AdultsUNIVERSITY OF TEXAS HLTH SCIENCE CENTER2017–2025
Molecular Transducers of Physical Activity Consortium Adult Clinical CenterCEDARS-SINAI MEDICAL CENTER2016–2025
Molecular Transducers of Physical Activity Consortium Adult Clinical CenterCEDARS-SINAI MEDICAL CENTER2016–2025
Molecular Transducers of Physical Activity Consortium Adult Clinical CenterCEDARS-SINAI MEDICAL CENTER2016–2025
Role Of TLR4 On Insulin Resistance In Human MuscleNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2012
Effect Of Age On Glucose And Lipid MetabolismNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
Role Of Ikk/Lkb/Nfkb Signaling In Insulin Resistance In Aging MuscleNational Institute On Aging2007–2009